Susan Z. Yanovski

Susan Z. Yanovski, co-director of the Office of Obesity Research at NIH, discusses a groundbreaking shift in how America approaches weight loss. She highlights recent advancements in weight-loss medications like semaglutide, which could change the treatment landscape. The conversation challenges the belief that weight loss is solely about willpower, instead emphasizing biological factors. Yanovski also addresses the societal impact of these drugs, from health care implications to how they might reshape perceptions of diet and responsibility.